@article{10737,
  keywords = {Dulaglutide, Glp-1 ra, Observational study, primary care, Subcutaneous semaglutide, Therapeutic inertia, Type 2 diabetes},
  author = {L. von Arx and J. Rachman and J. Webb and C. Casey and A. Patel and C. Diomatari and R. Wood and I. Idris},
  title = {Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care},
  year = {2023},
  journal = {Diabetes Obes Metab},
  edition = {2023/01/25},
  isbn = {1462-8902},
  doi = {10.1111/dom.14985},
  note = {1463-1326
von Arx, Lill-Brith
Orcid: 0000-0002-7170-6268
Rachman, Jonathan
Webb, Joanne
Casey, Caroline
Patel, Amisha
Diomatari, Christina
Wood, Robert
Idris, Iskandar
Journal Article
England
Diabetes Obes Metab. 2023 Jan 24. doi: 10.1111/dom.14985.},
  language = {eng},
}